Identification of new NY-ESO-1 epitopes recognized by CD4+...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000

Reexamination Certificate

active

07632506

ABSTRACT:
The invention relates to peptides which bind to MHC molecules of either Class I or Class II, and their use. The peptides consist of amino acid sequences found in the NY-ESO-1 molecule.

REFERENCES:
patent: 6251603 (2001-06-01), Jager et al.
patent: 6417165 (2002-07-01), Valmori et al.
patent: 6548064 (2003-04-01), Tureci et al.
patent: 6723832 (2004-04-01), Knuth et al.
patent: 6800730 (2004-10-01), Tureci et al.
patent: 7041502 (2006-05-01), Bilsborough et al.
patent: 7115729 (2006-10-01), Knuth et al.
patent: 7385044 (2008-06-01), Tureci et al.
patent: WO-0155393 (2001-08-01), None
patent: WO-03068800 (2003-08-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Identification of new NY-ESO-1 epitopes recognized by CD4+... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification of new NY-ESO-1 epitopes recognized by CD4+..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of new NY-ESO-1 epitopes recognized by CD4+... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4113925

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.